Clinical Trial Update: Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This trial update describes a dose-escalation and dose-expansion study of MDX2001 in patients with advanced solid tumors, currently recruiting for Phase 1/2 acr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Breast Cancer
• Cervical Cancer
• Colorectal Cancer
• Endometrial Cancer
• Esophageal Cancer
• Gastric Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• MDX2001

Snippet

Sponsor: ModeX Therapeutics, An OPKO Health Company | Conditions: Biliary Tract Cancer, Breast Cancer | Phase 1, Phase 2 | Status: RECRUITING